Andecaliximab - HY-P99351
Nur noch %1 verfügbar
Catalog #
HY-P99351
Ab
310,00 €
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF)[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99351/Andecaliximab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-Kinase/protease |
| Alternative Names | Anti-MMP9 Reference Antibody (andecaliximab) |
| CAS | 1518996-49-0 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | Phase 3 |
| Target | MMP |
| Application: | Cancer-Kinase/protease |
|---|